The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1055
ISSUE1055
June 18, 1999
Orlistat for Obesity
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Orlistat for Obesity
June 18, 1999 (Issue: 1055)
Orlistat, a lipase inhibitor that decreases absorption of fat from the gastrointestinal tract, is now available for treatment of obesity.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.